Shanghai Henlius Biotech

Biotech arm of Fosun with a focus of Monoclonal Antibodies

placeXuhui, Shanghai, China calendar_todayFounded 2010 groups3,602 employees language henlius.com

Innovation

68 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace steady. Cited 3,331 times.

YearFilings
20141
20152
20161
20182
20196
20207
202119
202221
202323
202430
202523
202614

Social engagement

Social engagement: 16.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include ShenZhen GTJA Investment Group, Fosun.

Investor typeCountShare
Venture capital433%
Private equity758%
Other / undisclosed18%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

29 Jul 2026 · Head of Commercial Development Lead, KSA · Saudi Arabia

Based on job postings tracked across public sources.

Recent activity

2 Jul 2026
Milestone
regulatory
30 Jun 2026
Milestone
HLX48
26 Jun 2026
Milestone
regulatory
Coming soon